Global Neurological Drugs Supply, Demand and Key Producers, 2023-2029
The global Neurological Drugs market size is expected to reach $ 196010 million by 2029, rising at a market growth of 7.1% CAGR during the forecast period (2023-2029).
Nervous system diseases are diseases that occur in the central nervous system, peripheral nervous system, and autonomic nervous system, mainly manifested in sensory, motor, consciousness, and autonomic dysfunction.
This report studies the global Neurological Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Neurological Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Neurological Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Neurological Drugs total production and demand, 2018-2029, (K Units)
Global Neurological Drugs total production value, 2018-2029, (USD Million)
Global Neurological Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Neurological Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Neurological Drugs domestic production, consumption, key domestic manufacturers and share
Global Neurological Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Neurological Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Neurological Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Neurological Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Ely Lilly, Actavis, Mylan, Randox, Intellipharmaceutics, Astrazeneca, Lundbeck and Allergan, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Neurological Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Neurological Drugs Market, By Region:
1. How big is the global Neurological Drugs market?
2. What is the demand of the global Neurological Drugs market?
3. What is the year over year growth of the global Neurological Drugs market?
4. What is the production and production value of the global Neurological Drugs market?
5. Who are the key producers in the global Neurological Drugs market?
6. What are the growth factors driving the market demand?
Nervous system diseases are diseases that occur in the central nervous system, peripheral nervous system, and autonomic nervous system, mainly manifested in sensory, motor, consciousness, and autonomic dysfunction.
This report studies the global Neurological Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Neurological Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Neurological Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Neurological Drugs total production and demand, 2018-2029, (K Units)
Global Neurological Drugs total production value, 2018-2029, (USD Million)
Global Neurological Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Neurological Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Neurological Drugs domestic production, consumption, key domestic manufacturers and share
Global Neurological Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Neurological Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Neurological Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Neurological Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Ely Lilly, Actavis, Mylan, Randox, Intellipharmaceutics, Astrazeneca, Lundbeck and Allergan, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Neurological Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Neurological Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Non-prescription drugs
- Prescription
- Hospital
- Clinic
- Pfizer
- Ely Lilly
- Actavis
- Mylan
- Randox
- Intellipharmaceutics
- Astrazeneca
- Lundbeck
- Allergan
- GSK
- Otsuka Pharmaceutical
- Takeda
- NHU Group
- Shionogi
- APOTEX
- North China Pharmaceutical
- Harbin Pharmaceutical Co., Ltd.
- Lukang Pharmaceutical
- Kelun Pharmaceutical
- Kehua Biology
1. How big is the global Neurological Drugs market?
2. What is the demand of the global Neurological Drugs market?
3. What is the year over year growth of the global Neurological Drugs market?
4. What is the production and production value of the global Neurological Drugs market?
5. Who are the key producers in the global Neurological Drugs market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Neurological Drugs Introduction
1.2 World Neurological Drugs Supply & Forecast
1.2.1 World Neurological Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World Neurological Drugs Production (2018-2029)
1.2.3 World Neurological Drugs Pricing Trends (2018-2029)
1.3 World Neurological Drugs Production by Region (Based on Production Site)
1.3.1 World Neurological Drugs Production Value by Region (2018-2029)
1.3.2 World Neurological Drugs Production by Region (2018-2029)
1.3.3 World Neurological Drugs Average Price by Region (2018-2029)
1.3.4 North America Neurological Drugs Production (2018-2029)
1.3.5 Europe Neurological Drugs Production (2018-2029)
1.3.6 China Neurological Drugs Production (2018-2029)
1.3.7 Japan Neurological Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Neurological Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Neurological Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Neurological Drugs Demand (2018-2029)
2.2 World Neurological Drugs Consumption by Region
2.2.1 World Neurological Drugs Consumption by Region (2018-2023)
2.2.2 World Neurological Drugs Consumption Forecast by Region (2024-2029)
2.3 United States Neurological Drugs Consumption (2018-2029)
2.4 China Neurological Drugs Consumption (2018-2029)
2.5 Europe Neurological Drugs Consumption (2018-2029)
2.6 Japan Neurological Drugs Consumption (2018-2029)
2.7 South Korea Neurological Drugs Consumption (2018-2029)
2.8 ASEAN Neurological Drugs Consumption (2018-2029)
2.9 India Neurological Drugs Consumption (2018-2029)
3 WORLD NEUROLOGICAL DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Neurological Drugs Production Value by Manufacturer (2018-2023)
3.2 World Neurological Drugs Production by Manufacturer (2018-2023)
3.3 World Neurological Drugs Average Price by Manufacturer (2018-2023)
3.4 Neurological Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Neurological Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Neurological Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for Neurological Drugs in 2022
3.6 Neurological Drugs Market: Overall Company Footprint Analysis
3.6.1 Neurological Drugs Market: Region Footprint
3.6.2 Neurological Drugs Market: Company Product Type Footprint
3.6.3 Neurological Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Neurological Drugs Production Value Comparison
4.1.1 United States VS China: Neurological Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Neurological Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Neurological Drugs Production Comparison
4.2.1 United States VS China: Neurological Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Neurological Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Neurological Drugs Consumption Comparison
4.3.1 United States VS China: Neurological Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Neurological Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Neurological Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Neurological Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Neurological Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers Neurological Drugs Production (2018-2023)
4.5 China Based Neurological Drugs Manufacturers and Market Share
4.5.1 China Based Neurological Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Neurological Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers Neurological Drugs Production (2018-2023)
4.6 Rest of World Based Neurological Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Neurological Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Neurological Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Neurological Drugs Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Neurological Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Non-prescription drugs
5.2.2 Prescription
5.3 Market Segment by Type
5.3.1 World Neurological Drugs Production by Type (2018-2029)
5.3.2 World Neurological Drugs Production Value by Type (2018-2029)
5.3.3 World Neurological Drugs Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Neurological Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Neurological Drugs Production by Application (2018-2029)
6.3.2 World Neurological Drugs Production Value by Application (2018-2029)
6.3.3 World Neurological Drugs Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Neurological Drugs Product and Services
7.1.4 Pfizer Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Ely Lilly
7.2.1 Ely Lilly Details
7.2.2 Ely Lilly Major Business
7.2.3 Ely Lilly Neurological Drugs Product and Services
7.2.4 Ely Lilly Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Ely Lilly Recent Developments/Updates
7.2.6 Ely Lilly Competitive Strengths & Weaknesses
7.3 Actavis
7.3.1 Actavis Details
7.3.2 Actavis Major Business
7.3.3 Actavis Neurological Drugs Product and Services
7.3.4 Actavis Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Actavis Recent Developments/Updates
7.3.6 Actavis Competitive Strengths & Weaknesses
7.4 Mylan
7.4.1 Mylan Details
7.4.2 Mylan Major Business
7.4.3 Mylan Neurological Drugs Product and Services
7.4.4 Mylan Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Mylan Recent Developments/Updates
7.4.6 Mylan Competitive Strengths & Weaknesses
7.5 Randox
7.5.1 Randox Details
7.5.2 Randox Major Business
7.5.3 Randox Neurological Drugs Product and Services
7.5.4 Randox Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Randox Recent Developments/Updates
7.5.6 Randox Competitive Strengths & Weaknesses
7.6 Intellipharmaceutics
7.6.1 Intellipharmaceutics Details
7.6.2 Intellipharmaceutics Major Business
7.6.3 Intellipharmaceutics Neurological Drugs Product and Services
7.6.4 Intellipharmaceutics Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Intellipharmaceutics Recent Developments/Updates
7.6.6 Intellipharmaceutics Competitive Strengths & Weaknesses
7.7 Astrazeneca
7.7.1 Astrazeneca Details
7.7.2 Astrazeneca Major Business
7.7.3 Astrazeneca Neurological Drugs Product and Services
7.7.4 Astrazeneca Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Astrazeneca Recent Developments/Updates
7.7.6 Astrazeneca Competitive Strengths & Weaknesses
7.8 Lundbeck
7.8.1 Lundbeck Details
7.8.2 Lundbeck Major Business
7.8.3 Lundbeck Neurological Drugs Product and Services
7.8.4 Lundbeck Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Lundbeck Recent Developments/Updates
7.8.6 Lundbeck Competitive Strengths & Weaknesses
7.9 Allergan
7.9.1 Allergan Details
7.9.2 Allergan Major Business
7.9.3 Allergan Neurological Drugs Product and Services
7.9.4 Allergan Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Allergan Recent Developments/Updates
7.9.6 Allergan Competitive Strengths & Weaknesses
7.10 GSK
7.10.1 GSK Details
7.10.2 GSK Major Business
7.10.3 GSK Neurological Drugs Product and Services
7.10.4 GSK Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 GSK Recent Developments/Updates
7.10.6 GSK Competitive Strengths & Weaknesses
7.11 Otsuka Pharmaceutical
7.11.1 Otsuka Pharmaceutical Details
7.11.2 Otsuka Pharmaceutical Major Business
7.11.3 Otsuka Pharmaceutical Neurological Drugs Product and Services
7.11.4 Otsuka Pharmaceutical Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Otsuka Pharmaceutical Recent Developments/Updates
7.11.6 Otsuka Pharmaceutical Competitive Strengths & Weaknesses
7.12 Takeda
7.12.1 Takeda Details
7.12.2 Takeda Major Business
7.12.3 Takeda Neurological Drugs Product and Services
7.12.4 Takeda Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Takeda Recent Developments/Updates
7.12.6 Takeda Competitive Strengths & Weaknesses
7.13 NHU Group
7.13.1 NHU Group Details
7.13.2 NHU Group Major Business
7.13.3 NHU Group Neurological Drugs Product and Services
7.13.4 NHU Group Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 NHU Group Recent Developments/Updates
7.13.6 NHU Group Competitive Strengths & Weaknesses
7.14 Shionogi
7.14.1 Shionogi Details
7.14.2 Shionogi Major Business
7.14.3 Shionogi Neurological Drugs Product and Services
7.14.4 Shionogi Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Shionogi Recent Developments/Updates
7.14.6 Shionogi Competitive Strengths & Weaknesses
7.15 APOTEX
7.15.1 APOTEX Details
7.15.2 APOTEX Major Business
7.15.3 APOTEX Neurological Drugs Product and Services
7.15.4 APOTEX Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 APOTEX Recent Developments/Updates
7.15.6 APOTEX Competitive Strengths & Weaknesses
7.16 North China Pharmaceutical
7.16.1 North China Pharmaceutical Details
7.16.2 North China Pharmaceutical Major Business
7.16.3 North China Pharmaceutical Neurological Drugs Product and Services
7.16.4 North China Pharmaceutical Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 North China Pharmaceutical Recent Developments/Updates
7.16.6 North China Pharmaceutical Competitive Strengths & Weaknesses
7.17 Harbin Pharmaceutical Co., Ltd.
7.17.1 Harbin Pharmaceutical Co., Ltd. Details
7.17.2 Harbin Pharmaceutical Co., Ltd. Major Business
7.17.3 Harbin Pharmaceutical Co., Ltd. Neurological Drugs Product and Services
7.17.4 Harbin Pharmaceutical Co., Ltd. Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Harbin Pharmaceutical Co., Ltd. Recent Developments/Updates
7.17.6 Harbin Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.18 Lukang Pharmaceutical
7.18.1 Lukang Pharmaceutical Details
7.18.2 Lukang Pharmaceutical Major Business
7.18.3 Lukang Pharmaceutical Neurological Drugs Product and Services
7.18.4 Lukang Pharmaceutical Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Lukang Pharmaceutical Recent Developments/Updates
7.18.6 Lukang Pharmaceutical Competitive Strengths & Weaknesses
7.19 Kelun Pharmaceutical
7.19.1 Kelun Pharmaceutical Details
7.19.2 Kelun Pharmaceutical Major Business
7.19.3 Kelun Pharmaceutical Neurological Drugs Product and Services
7.19.4 Kelun Pharmaceutical Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Kelun Pharmaceutical Recent Developments/Updates
7.19.6 Kelun Pharmaceutical Competitive Strengths & Weaknesses
7.20 Kehua Biology
7.20.1 Kehua Biology Details
7.20.2 Kehua Biology Major Business
7.20.3 Kehua Biology Neurological Drugs Product and Services
7.20.4 Kehua Biology Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 Kehua Biology Recent Developments/Updates
7.20.6 Kehua Biology Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Neurological Drugs Industry Chain
8.2 Neurological Drugs Upstream Analysis
8.2.1 Neurological Drugs Core Raw Materials
8.2.2 Main Manufacturers of Neurological Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Neurological Drugs Production Mode
8.6 Neurological Drugs Procurement Model
8.7 Neurological Drugs Industry Sales Model and Sales Channels
8.7.1 Neurological Drugs Sales Model
8.7.2 Neurological Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Neurological Drugs Introduction
1.2 World Neurological Drugs Supply & Forecast
1.2.1 World Neurological Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World Neurological Drugs Production (2018-2029)
1.2.3 World Neurological Drugs Pricing Trends (2018-2029)
1.3 World Neurological Drugs Production by Region (Based on Production Site)
1.3.1 World Neurological Drugs Production Value by Region (2018-2029)
1.3.2 World Neurological Drugs Production by Region (2018-2029)
1.3.3 World Neurological Drugs Average Price by Region (2018-2029)
1.3.4 North America Neurological Drugs Production (2018-2029)
1.3.5 Europe Neurological Drugs Production (2018-2029)
1.3.6 China Neurological Drugs Production (2018-2029)
1.3.7 Japan Neurological Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Neurological Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Neurological Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Neurological Drugs Demand (2018-2029)
2.2 World Neurological Drugs Consumption by Region
2.2.1 World Neurological Drugs Consumption by Region (2018-2023)
2.2.2 World Neurological Drugs Consumption Forecast by Region (2024-2029)
2.3 United States Neurological Drugs Consumption (2018-2029)
2.4 China Neurological Drugs Consumption (2018-2029)
2.5 Europe Neurological Drugs Consumption (2018-2029)
2.6 Japan Neurological Drugs Consumption (2018-2029)
2.7 South Korea Neurological Drugs Consumption (2018-2029)
2.8 ASEAN Neurological Drugs Consumption (2018-2029)
2.9 India Neurological Drugs Consumption (2018-2029)
3 WORLD NEUROLOGICAL DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Neurological Drugs Production Value by Manufacturer (2018-2023)
3.2 World Neurological Drugs Production by Manufacturer (2018-2023)
3.3 World Neurological Drugs Average Price by Manufacturer (2018-2023)
3.4 Neurological Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Neurological Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Neurological Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for Neurological Drugs in 2022
3.6 Neurological Drugs Market: Overall Company Footprint Analysis
3.6.1 Neurological Drugs Market: Region Footprint
3.6.2 Neurological Drugs Market: Company Product Type Footprint
3.6.3 Neurological Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Neurological Drugs Production Value Comparison
4.1.1 United States VS China: Neurological Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Neurological Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Neurological Drugs Production Comparison
4.2.1 United States VS China: Neurological Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Neurological Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Neurological Drugs Consumption Comparison
4.3.1 United States VS China: Neurological Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Neurological Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Neurological Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Neurological Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Neurological Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers Neurological Drugs Production (2018-2023)
4.5 China Based Neurological Drugs Manufacturers and Market Share
4.5.1 China Based Neurological Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Neurological Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers Neurological Drugs Production (2018-2023)
4.6 Rest of World Based Neurological Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Neurological Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Neurological Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Neurological Drugs Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Neurological Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Non-prescription drugs
5.2.2 Prescription
5.3 Market Segment by Type
5.3.1 World Neurological Drugs Production by Type (2018-2029)
5.3.2 World Neurological Drugs Production Value by Type (2018-2029)
5.3.3 World Neurological Drugs Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Neurological Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Neurological Drugs Production by Application (2018-2029)
6.3.2 World Neurological Drugs Production Value by Application (2018-2029)
6.3.3 World Neurological Drugs Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Neurological Drugs Product and Services
7.1.4 Pfizer Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Ely Lilly
7.2.1 Ely Lilly Details
7.2.2 Ely Lilly Major Business
7.2.3 Ely Lilly Neurological Drugs Product and Services
7.2.4 Ely Lilly Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Ely Lilly Recent Developments/Updates
7.2.6 Ely Lilly Competitive Strengths & Weaknesses
7.3 Actavis
7.3.1 Actavis Details
7.3.2 Actavis Major Business
7.3.3 Actavis Neurological Drugs Product and Services
7.3.4 Actavis Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Actavis Recent Developments/Updates
7.3.6 Actavis Competitive Strengths & Weaknesses
7.4 Mylan
7.4.1 Mylan Details
7.4.2 Mylan Major Business
7.4.3 Mylan Neurological Drugs Product and Services
7.4.4 Mylan Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Mylan Recent Developments/Updates
7.4.6 Mylan Competitive Strengths & Weaknesses
7.5 Randox
7.5.1 Randox Details
7.5.2 Randox Major Business
7.5.3 Randox Neurological Drugs Product and Services
7.5.4 Randox Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Randox Recent Developments/Updates
7.5.6 Randox Competitive Strengths & Weaknesses
7.6 Intellipharmaceutics
7.6.1 Intellipharmaceutics Details
7.6.2 Intellipharmaceutics Major Business
7.6.3 Intellipharmaceutics Neurological Drugs Product and Services
7.6.4 Intellipharmaceutics Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Intellipharmaceutics Recent Developments/Updates
7.6.6 Intellipharmaceutics Competitive Strengths & Weaknesses
7.7 Astrazeneca
7.7.1 Astrazeneca Details
7.7.2 Astrazeneca Major Business
7.7.3 Astrazeneca Neurological Drugs Product and Services
7.7.4 Astrazeneca Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Astrazeneca Recent Developments/Updates
7.7.6 Astrazeneca Competitive Strengths & Weaknesses
7.8 Lundbeck
7.8.1 Lundbeck Details
7.8.2 Lundbeck Major Business
7.8.3 Lundbeck Neurological Drugs Product and Services
7.8.4 Lundbeck Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Lundbeck Recent Developments/Updates
7.8.6 Lundbeck Competitive Strengths & Weaknesses
7.9 Allergan
7.9.1 Allergan Details
7.9.2 Allergan Major Business
7.9.3 Allergan Neurological Drugs Product and Services
7.9.4 Allergan Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Allergan Recent Developments/Updates
7.9.6 Allergan Competitive Strengths & Weaknesses
7.10 GSK
7.10.1 GSK Details
7.10.2 GSK Major Business
7.10.3 GSK Neurological Drugs Product and Services
7.10.4 GSK Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 GSK Recent Developments/Updates
7.10.6 GSK Competitive Strengths & Weaknesses
7.11 Otsuka Pharmaceutical
7.11.1 Otsuka Pharmaceutical Details
7.11.2 Otsuka Pharmaceutical Major Business
7.11.3 Otsuka Pharmaceutical Neurological Drugs Product and Services
7.11.4 Otsuka Pharmaceutical Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Otsuka Pharmaceutical Recent Developments/Updates
7.11.6 Otsuka Pharmaceutical Competitive Strengths & Weaknesses
7.12 Takeda
7.12.1 Takeda Details
7.12.2 Takeda Major Business
7.12.3 Takeda Neurological Drugs Product and Services
7.12.4 Takeda Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Takeda Recent Developments/Updates
7.12.6 Takeda Competitive Strengths & Weaknesses
7.13 NHU Group
7.13.1 NHU Group Details
7.13.2 NHU Group Major Business
7.13.3 NHU Group Neurological Drugs Product and Services
7.13.4 NHU Group Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 NHU Group Recent Developments/Updates
7.13.6 NHU Group Competitive Strengths & Weaknesses
7.14 Shionogi
7.14.1 Shionogi Details
7.14.2 Shionogi Major Business
7.14.3 Shionogi Neurological Drugs Product and Services
7.14.4 Shionogi Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Shionogi Recent Developments/Updates
7.14.6 Shionogi Competitive Strengths & Weaknesses
7.15 APOTEX
7.15.1 APOTEX Details
7.15.2 APOTEX Major Business
7.15.3 APOTEX Neurological Drugs Product and Services
7.15.4 APOTEX Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 APOTEX Recent Developments/Updates
7.15.6 APOTEX Competitive Strengths & Weaknesses
7.16 North China Pharmaceutical
7.16.1 North China Pharmaceutical Details
7.16.2 North China Pharmaceutical Major Business
7.16.3 North China Pharmaceutical Neurological Drugs Product and Services
7.16.4 North China Pharmaceutical Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 North China Pharmaceutical Recent Developments/Updates
7.16.6 North China Pharmaceutical Competitive Strengths & Weaknesses
7.17 Harbin Pharmaceutical Co., Ltd.
7.17.1 Harbin Pharmaceutical Co., Ltd. Details
7.17.2 Harbin Pharmaceutical Co., Ltd. Major Business
7.17.3 Harbin Pharmaceutical Co., Ltd. Neurological Drugs Product and Services
7.17.4 Harbin Pharmaceutical Co., Ltd. Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Harbin Pharmaceutical Co., Ltd. Recent Developments/Updates
7.17.6 Harbin Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.18 Lukang Pharmaceutical
7.18.1 Lukang Pharmaceutical Details
7.18.2 Lukang Pharmaceutical Major Business
7.18.3 Lukang Pharmaceutical Neurological Drugs Product and Services
7.18.4 Lukang Pharmaceutical Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Lukang Pharmaceutical Recent Developments/Updates
7.18.6 Lukang Pharmaceutical Competitive Strengths & Weaknesses
7.19 Kelun Pharmaceutical
7.19.1 Kelun Pharmaceutical Details
7.19.2 Kelun Pharmaceutical Major Business
7.19.3 Kelun Pharmaceutical Neurological Drugs Product and Services
7.19.4 Kelun Pharmaceutical Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Kelun Pharmaceutical Recent Developments/Updates
7.19.6 Kelun Pharmaceutical Competitive Strengths & Weaknesses
7.20 Kehua Biology
7.20.1 Kehua Biology Details
7.20.2 Kehua Biology Major Business
7.20.3 Kehua Biology Neurological Drugs Product and Services
7.20.4 Kehua Biology Neurological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 Kehua Biology Recent Developments/Updates
7.20.6 Kehua Biology Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Neurological Drugs Industry Chain
8.2 Neurological Drugs Upstream Analysis
8.2.1 Neurological Drugs Core Raw Materials
8.2.2 Main Manufacturers of Neurological Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Neurological Drugs Production Mode
8.6 Neurological Drugs Procurement Model
8.7 Neurological Drugs Industry Sales Model and Sales Channels
8.7.1 Neurological Drugs Sales Model
8.7.2 Neurological Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Neurological Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Neurological Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World Neurological Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World Neurological Drugs Production Value Market Share by Region (2018-2023)
Table 5. World Neurological Drugs Production Value Market Share by Region (2024-2029)
Table 6. World Neurological Drugs Production by Region (2018-2023) & (K Units)
Table 7. World Neurological Drugs Production by Region (2024-2029) & (K Units)
Table 8. World Neurological Drugs Production Market Share by Region (2018-2023)
Table 9. World Neurological Drugs Production Market Share by Region (2024-2029)
Table 10. World Neurological Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Neurological Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Neurological Drugs Major Market Trends
Table 13. World Neurological Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Neurological Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World Neurological Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Neurological Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Neurological Drugs Producers in 2022
Table 18. World Neurological Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Neurological Drugs Producers in 2022
Table 20. World Neurological Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Neurological Drugs Company Evaluation Quadrant
Table 22. World Neurological Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Neurological Drugs Production Site of Key Manufacturer
Table 24. Neurological Drugs Market: Company Product Type Footprint
Table 25. Neurological Drugs Market: Company Product Application Footprint
Table 26. Neurological Drugs Competitive Factors
Table 27. Neurological Drugs New Entrant and Capacity Expansion Plans
Table 28. Neurological Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Neurological Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Neurological Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Neurological Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Neurological Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Neurological Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Neurological Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Neurological Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Neurological Drugs Production Market Share (2018-2023)
Table 37. China Based Neurological Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Neurological Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Neurological Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Neurological Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Neurological Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based Neurological Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Neurological Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Neurological Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Neurological Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Neurological Drugs Production Market Share (2018-2023)
Table 47. World Neurological Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Neurological Drugs Production by Type (2018-2023) & (K Units)
Table 49. World Neurological Drugs Production by Type (2024-2029) & (K Units)
Table 50. World Neurological Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World Neurological Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World Neurological Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Neurological Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Neurological Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Neurological Drugs Production by Application (2018-2023) & (K Units)
Table 56. World Neurological Drugs Production by Application (2024-2029) & (K Units)
Table 57. World Neurological Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World Neurological Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World Neurological Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Neurological Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Neurological Drugs Product and Services
Table 64. Pfizer Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Ely Lilly Basic Information, Manufacturing Base and Competitors
Table 68. Ely Lilly Major Business
Table 69. Ely Lilly Neurological Drugs Product and Services
Table 70. Ely Lilly Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Ely Lilly Recent Developments/Updates
Table 72. Ely Lilly Competitive Strengths & Weaknesses
Table 73. Actavis Basic Information, Manufacturing Base and Competitors
Table 74. Actavis Major Business
Table 75. Actavis Neurological Drugs Product and Services
Table 76. Actavis Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Actavis Recent Developments/Updates
Table 78. Actavis Competitive Strengths & Weaknesses
Table 79. Mylan Basic Information, Manufacturing Base and Competitors
Table 80. Mylan Major Business
Table 81. Mylan Neurological Drugs Product and Services
Table 82. Mylan Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Mylan Recent Developments/Updates
Table 84. Mylan Competitive Strengths & Weaknesses
Table 85. Randox Basic Information, Manufacturing Base and Competitors
Table 86. Randox Major Business
Table 87. Randox Neurological Drugs Product and Services
Table 88. Randox Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Randox Recent Developments/Updates
Table 90. Randox Competitive Strengths & Weaknesses
Table 91. Intellipharmaceutics Basic Information, Manufacturing Base and Competitors
Table 92. Intellipharmaceutics Major Business
Table 93. Intellipharmaceutics Neurological Drugs Product and Services
Table 94. Intellipharmaceutics Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Intellipharmaceutics Recent Developments/Updates
Table 96. Intellipharmaceutics Competitive Strengths & Weaknesses
Table 97. Astrazeneca Basic Information, Manufacturing Base and Competitors
Table 98. Astrazeneca Major Business
Table 99. Astrazeneca Neurological Drugs Product and Services
Table 100. Astrazeneca Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Astrazeneca Recent Developments/Updates
Table 102. Astrazeneca Competitive Strengths & Weaknesses
Table 103. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 104. Lundbeck Major Business
Table 105. Lundbeck Neurological Drugs Product and Services
Table 106. Lundbeck Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Lundbeck Recent Developments/Updates
Table 108. Lundbeck Competitive Strengths & Weaknesses
Table 109. Allergan Basic Information, Manufacturing Base and Competitors
Table 110. Allergan Major Business
Table 111. Allergan Neurological Drugs Product and Services
Table 112. Allergan Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Allergan Recent Developments/Updates
Table 114. Allergan Competitive Strengths & Weaknesses
Table 115. GSK Basic Information, Manufacturing Base and Competitors
Table 116. GSK Major Business
Table 117. GSK Neurological Drugs Product and Services
Table 118. GSK Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. GSK Recent Developments/Updates
Table 120. GSK Competitive Strengths & Weaknesses
Table 121. Otsuka Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 122. Otsuka Pharmaceutical Major Business
Table 123. Otsuka Pharmaceutical Neurological Drugs Product and Services
Table 124. Otsuka Pharmaceutical Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Otsuka Pharmaceutical Recent Developments/Updates
Table 126. Otsuka Pharmaceutical Competitive Strengths & Weaknesses
Table 127. Takeda Basic Information, Manufacturing Base and Competitors
Table 128. Takeda Major Business
Table 129. Takeda Neurological Drugs Product and Services
Table 130. Takeda Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Takeda Recent Developments/Updates
Table 132. Takeda Competitive Strengths & Weaknesses
Table 133. NHU Group Basic Information, Manufacturing Base and Competitors
Table 134. NHU Group Major Business
Table 135. NHU Group Neurological Drugs Product and Services
Table 136. NHU Group Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. NHU Group Recent Developments/Updates
Table 138. NHU Group Competitive Strengths & Weaknesses
Table 139. Shionogi Basic Information, Manufacturing Base and Competitors
Table 140. Shionogi Major Business
Table 141. Shionogi Neurological Drugs Product and Services
Table 142. Shionogi Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Shionogi Recent Developments/Updates
Table 144. Shionogi Competitive Strengths & Weaknesses
Table 145. APOTEX Basic Information, Manufacturing Base and Competitors
Table 146. APOTEX Major Business
Table 147. APOTEX Neurological Drugs Product and Services
Table 148. APOTEX Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. APOTEX Recent Developments/Updates
Table 150. APOTEX Competitive Strengths & Weaknesses
Table 151. North China Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 152. North China Pharmaceutical Major Business
Table 153. North China Pharmaceutical Neurological Drugs Product and Services
Table 154. North China Pharmaceutical Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. North China Pharmaceutical Recent Developments/Updates
Table 156. North China Pharmaceutical Competitive Strengths & Weaknesses
Table 157. Harbin Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 158. Harbin Pharmaceutical Co., Ltd. Major Business
Table 159. Harbin Pharmaceutical Co., Ltd. Neurological Drugs Product and Services
Table 160. Harbin Pharmaceutical Co., Ltd. Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Harbin Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 162. Harbin Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 163. Lukang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 164. Lukang Pharmaceutical Major Business
Table 165. Lukang Pharmaceutical Neurological Drugs Product and Services
Table 166. Lukang Pharmaceutical Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Lukang Pharmaceutical Recent Developments/Updates
Table 168. Lukang Pharmaceutical Competitive Strengths & Weaknesses
Table 169. Kelun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 170. Kelun Pharmaceutical Major Business
Table 171. Kelun Pharmaceutical Neurological Drugs Product and Services
Table 172. Kelun Pharmaceutical Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Kelun Pharmaceutical Recent Developments/Updates
Table 174. Kehua Biology Basic Information, Manufacturing Base and Competitors
Table 175. Kehua Biology Major Business
Table 176. Kehua Biology Neurological Drugs Product and Services
Table 177. Kehua Biology Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 178. Global Key Players of Neurological Drugs Upstream (Raw Materials)
Table 179. Neurological Drugs Typical Customers
Table 180. Neurological Drugs Typical Distributors
Table 1. World Neurological Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Neurological Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World Neurological Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World Neurological Drugs Production Value Market Share by Region (2018-2023)
Table 5. World Neurological Drugs Production Value Market Share by Region (2024-2029)
Table 6. World Neurological Drugs Production by Region (2018-2023) & (K Units)
Table 7. World Neurological Drugs Production by Region (2024-2029) & (K Units)
Table 8. World Neurological Drugs Production Market Share by Region (2018-2023)
Table 9. World Neurological Drugs Production Market Share by Region (2024-2029)
Table 10. World Neurological Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Neurological Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Neurological Drugs Major Market Trends
Table 13. World Neurological Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Neurological Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World Neurological Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Neurological Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Neurological Drugs Producers in 2022
Table 18. World Neurological Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Neurological Drugs Producers in 2022
Table 20. World Neurological Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Neurological Drugs Company Evaluation Quadrant
Table 22. World Neurological Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Neurological Drugs Production Site of Key Manufacturer
Table 24. Neurological Drugs Market: Company Product Type Footprint
Table 25. Neurological Drugs Market: Company Product Application Footprint
Table 26. Neurological Drugs Competitive Factors
Table 27. Neurological Drugs New Entrant and Capacity Expansion Plans
Table 28. Neurological Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Neurological Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Neurological Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Neurological Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Neurological Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Neurological Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Neurological Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Neurological Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Neurological Drugs Production Market Share (2018-2023)
Table 37. China Based Neurological Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Neurological Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Neurological Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Neurological Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Neurological Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based Neurological Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Neurological Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Neurological Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Neurological Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Neurological Drugs Production Market Share (2018-2023)
Table 47. World Neurological Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Neurological Drugs Production by Type (2018-2023) & (K Units)
Table 49. World Neurological Drugs Production by Type (2024-2029) & (K Units)
Table 50. World Neurological Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World Neurological Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World Neurological Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Neurological Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Neurological Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Neurological Drugs Production by Application (2018-2023) & (K Units)
Table 56. World Neurological Drugs Production by Application (2024-2029) & (K Units)
Table 57. World Neurological Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World Neurological Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World Neurological Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Neurological Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Neurological Drugs Product and Services
Table 64. Pfizer Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Ely Lilly Basic Information, Manufacturing Base and Competitors
Table 68. Ely Lilly Major Business
Table 69. Ely Lilly Neurological Drugs Product and Services
Table 70. Ely Lilly Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Ely Lilly Recent Developments/Updates
Table 72. Ely Lilly Competitive Strengths & Weaknesses
Table 73. Actavis Basic Information, Manufacturing Base and Competitors
Table 74. Actavis Major Business
Table 75. Actavis Neurological Drugs Product and Services
Table 76. Actavis Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Actavis Recent Developments/Updates
Table 78. Actavis Competitive Strengths & Weaknesses
Table 79. Mylan Basic Information, Manufacturing Base and Competitors
Table 80. Mylan Major Business
Table 81. Mylan Neurological Drugs Product and Services
Table 82. Mylan Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Mylan Recent Developments/Updates
Table 84. Mylan Competitive Strengths & Weaknesses
Table 85. Randox Basic Information, Manufacturing Base and Competitors
Table 86. Randox Major Business
Table 87. Randox Neurological Drugs Product and Services
Table 88. Randox Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Randox Recent Developments/Updates
Table 90. Randox Competitive Strengths & Weaknesses
Table 91. Intellipharmaceutics Basic Information, Manufacturing Base and Competitors
Table 92. Intellipharmaceutics Major Business
Table 93. Intellipharmaceutics Neurological Drugs Product and Services
Table 94. Intellipharmaceutics Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Intellipharmaceutics Recent Developments/Updates
Table 96. Intellipharmaceutics Competitive Strengths & Weaknesses
Table 97. Astrazeneca Basic Information, Manufacturing Base and Competitors
Table 98. Astrazeneca Major Business
Table 99. Astrazeneca Neurological Drugs Product and Services
Table 100. Astrazeneca Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Astrazeneca Recent Developments/Updates
Table 102. Astrazeneca Competitive Strengths & Weaknesses
Table 103. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 104. Lundbeck Major Business
Table 105. Lundbeck Neurological Drugs Product and Services
Table 106. Lundbeck Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Lundbeck Recent Developments/Updates
Table 108. Lundbeck Competitive Strengths & Weaknesses
Table 109. Allergan Basic Information, Manufacturing Base and Competitors
Table 110. Allergan Major Business
Table 111. Allergan Neurological Drugs Product and Services
Table 112. Allergan Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Allergan Recent Developments/Updates
Table 114. Allergan Competitive Strengths & Weaknesses
Table 115. GSK Basic Information, Manufacturing Base and Competitors
Table 116. GSK Major Business
Table 117. GSK Neurological Drugs Product and Services
Table 118. GSK Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. GSK Recent Developments/Updates
Table 120. GSK Competitive Strengths & Weaknesses
Table 121. Otsuka Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 122. Otsuka Pharmaceutical Major Business
Table 123. Otsuka Pharmaceutical Neurological Drugs Product and Services
Table 124. Otsuka Pharmaceutical Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Otsuka Pharmaceutical Recent Developments/Updates
Table 126. Otsuka Pharmaceutical Competitive Strengths & Weaknesses
Table 127. Takeda Basic Information, Manufacturing Base and Competitors
Table 128. Takeda Major Business
Table 129. Takeda Neurological Drugs Product and Services
Table 130. Takeda Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Takeda Recent Developments/Updates
Table 132. Takeda Competitive Strengths & Weaknesses
Table 133. NHU Group Basic Information, Manufacturing Base and Competitors
Table 134. NHU Group Major Business
Table 135. NHU Group Neurological Drugs Product and Services
Table 136. NHU Group Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. NHU Group Recent Developments/Updates
Table 138. NHU Group Competitive Strengths & Weaknesses
Table 139. Shionogi Basic Information, Manufacturing Base and Competitors
Table 140. Shionogi Major Business
Table 141. Shionogi Neurological Drugs Product and Services
Table 142. Shionogi Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Shionogi Recent Developments/Updates
Table 144. Shionogi Competitive Strengths & Weaknesses
Table 145. APOTEX Basic Information, Manufacturing Base and Competitors
Table 146. APOTEX Major Business
Table 147. APOTEX Neurological Drugs Product and Services
Table 148. APOTEX Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. APOTEX Recent Developments/Updates
Table 150. APOTEX Competitive Strengths & Weaknesses
Table 151. North China Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 152. North China Pharmaceutical Major Business
Table 153. North China Pharmaceutical Neurological Drugs Product and Services
Table 154. North China Pharmaceutical Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. North China Pharmaceutical Recent Developments/Updates
Table 156. North China Pharmaceutical Competitive Strengths & Weaknesses
Table 157. Harbin Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 158. Harbin Pharmaceutical Co., Ltd. Major Business
Table 159. Harbin Pharmaceutical Co., Ltd. Neurological Drugs Product and Services
Table 160. Harbin Pharmaceutical Co., Ltd. Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Harbin Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 162. Harbin Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 163. Lukang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 164. Lukang Pharmaceutical Major Business
Table 165. Lukang Pharmaceutical Neurological Drugs Product and Services
Table 166. Lukang Pharmaceutical Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Lukang Pharmaceutical Recent Developments/Updates
Table 168. Lukang Pharmaceutical Competitive Strengths & Weaknesses
Table 169. Kelun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 170. Kelun Pharmaceutical Major Business
Table 171. Kelun Pharmaceutical Neurological Drugs Product and Services
Table 172. Kelun Pharmaceutical Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Kelun Pharmaceutical Recent Developments/Updates
Table 174. Kehua Biology Basic Information, Manufacturing Base and Competitors
Table 175. Kehua Biology Major Business
Table 176. Kehua Biology Neurological Drugs Product and Services
Table 177. Kehua Biology Neurological Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 178. Global Key Players of Neurological Drugs Upstream (Raw Materials)
Table 179. Neurological Drugs Typical Customers
Table 180. Neurological Drugs Typical Distributors
LIST OF FIGURES
Figure 1. Neurological Drugs Picture
Figure 2. World Neurological Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Neurological Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Neurological Drugs Production (2018-2029) & (K Units)
Figure 5. World Neurological Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World Neurological Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World Neurological Drugs Production Market Share by Region (2018-2029)
Figure 8. North America Neurological Drugs Production (2018-2029) & (K Units)
Figure 9. Europe Neurological Drugs Production (2018-2029) & (K Units)
Figure 10. China Neurological Drugs Production (2018-2029) & (K Units)
Figure 11. Japan Neurological Drugs Production (2018-2029) & (K Units)
Figure 12. Neurological Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Neurological Drugs Consumption (2018-2029) & (K Units)
Figure 15. World Neurological Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States Neurological Drugs Consumption (2018-2029) & (K Units)
Figure 17. China Neurological Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe Neurological Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan Neurological Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea Neurological Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Neurological Drugs Consumption (2018-2029) & (K Units)
Figure 22. India Neurological Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Neurological Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Neurological Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Neurological Drugs Markets in 2022
Figure 26. United States VS China: Neurological Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Neurological Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Neurological Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Neurological Drugs Production Market Share 2022
Figure 30. China Based Manufacturers Neurological Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Neurological Drugs Production Market Share 2022
Figure 32. World Neurological Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Neurological Drugs Production Value Market Share by Type in 2022
Figure 34. Non-prescription drugs
Figure 35. Prescription
Figure 36. World Neurological Drugs Production Market Share by Type (2018-2029)
Figure 37. World Neurological Drugs Production Value Market Share by Type (2018-2029)
Figure 38. World Neurological Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Neurological Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Neurological Drugs Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Neurological Drugs Production Market Share by Application (2018-2029)
Figure 44. World Neurological Drugs Production Value Market Share by Application (2018-2029)
Figure 45. World Neurological Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Neurological Drugs Industry Chain
Figure 47. Neurological Drugs Procurement Model
Figure 48. Neurological Drugs Sales Model
Figure 49. Neurological Drugs Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
Figure 1. Neurological Drugs Picture
Figure 2. World Neurological Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Neurological Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Neurological Drugs Production (2018-2029) & (K Units)
Figure 5. World Neurological Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World Neurological Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World Neurological Drugs Production Market Share by Region (2018-2029)
Figure 8. North America Neurological Drugs Production (2018-2029) & (K Units)
Figure 9. Europe Neurological Drugs Production (2018-2029) & (K Units)
Figure 10. China Neurological Drugs Production (2018-2029) & (K Units)
Figure 11. Japan Neurological Drugs Production (2018-2029) & (K Units)
Figure 12. Neurological Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Neurological Drugs Consumption (2018-2029) & (K Units)
Figure 15. World Neurological Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States Neurological Drugs Consumption (2018-2029) & (K Units)
Figure 17. China Neurological Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe Neurological Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan Neurological Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea Neurological Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Neurological Drugs Consumption (2018-2029) & (K Units)
Figure 22. India Neurological Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Neurological Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Neurological Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Neurological Drugs Markets in 2022
Figure 26. United States VS China: Neurological Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Neurological Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Neurological Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Neurological Drugs Production Market Share 2022
Figure 30. China Based Manufacturers Neurological Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Neurological Drugs Production Market Share 2022
Figure 32. World Neurological Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Neurological Drugs Production Value Market Share by Type in 2022
Figure 34. Non-prescription drugs
Figure 35. Prescription
Figure 36. World Neurological Drugs Production Market Share by Type (2018-2029)
Figure 37. World Neurological Drugs Production Value Market Share by Type (2018-2029)
Figure 38. World Neurological Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Neurological Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Neurological Drugs Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Neurological Drugs Production Market Share by Application (2018-2029)
Figure 44. World Neurological Drugs Production Value Market Share by Application (2018-2029)
Figure 45. World Neurological Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Neurological Drugs Industry Chain
Figure 47. Neurological Drugs Procurement Model
Figure 48. Neurological Drugs Sales Model
Figure 49. Neurological Drugs Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
